How Risky Is That Risk Sharing Agreement? Mean-Variance Tradeoffs and Unintended Consequences of Six Common Risk Sharing Agreements

Background. Pharmaceutical risk sharing agreements (RSAs) are commonly used to manage uncertainties in costs and/or clinical benefits when new drugs are added to a formulary. However, existing mathematical models of RSAs ignore the impact of RSAs on clinical and financial risk. Methods. We develop a...

Descripción completa

Detalles Bibliográficos
Autor principal: Zaric, Gregory S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876771/
https://www.ncbi.nlm.nih.gov/pubmed/33623819
http://dx.doi.org/10.1177/2381468321990404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876771/
https://www.ncbi.nlm.nih.gov/pubmed/33623819
http://dx.doi.org/10.1177/2381468321990404

Ejemplares similares